Abstract
In an era where life-sustaining technology offers physicians unprecedented powers to prolong survival in terminal illness, the question of how end of life decisions are made has become a major subject of study and debate. Amyotrophic lateral sclerosis (ALS) is a disease in which physical ability declines while mental capacity most often remains intact. Since most patients with ALS die of respiratory failure, a distinguishing feature of this disease is whether a patient is offered and accepts a chance to go on long-term mechanical ventilation. This unusual feature makes ALS a compelling model for studying end of life decisions in different countries. This paper reviews the literature and presents preliminary data on how end of life decisions in ALS are made in the US, Great Britain, and Japan. We address this issue by examining how cultural differences in truth-telling and informed consent, societal differences in attitudes toward the use of artificial life support, and legal differences in the role and status of advance directives in each country influenced decisions in the following three groups of patients: (1) the mentally competent; (2) mentally incompetent patients who previously completed advance directives when competent...Continue Reading
References
Sep 1, 1991·Mayo Clinic Proceedings·M D SilversteinM Siegler
Nov 22, 1995·JAMA : the Journal of the American Medical Association
May 1, 1995·Journal of the Neurological Sciences·O GarofaloP N Leigh
Jul 1, 1994·Journal of the Neurological Sciences·M SostarkoD Vranjes
Feb 1, 1993·Neurology·A H MossM Siegler
Nov 25, 2000·Journal of the Neurological Sciences·D NearyD M Mann
Citations
Nov 7, 2002·Health Care for Women International·Misae Ito, Nancy C Sharts-Hopko
Mar 22, 2013·PloS One·Wei ZhaoSheng-Yuan Yu
Dec 12, 2012·Patient Preference and Adherence·Anne HogdenMatthew C Kiernan
Jun 2, 2011·Journal of Epidemiology·Kiwamu NagoshiHidehiro Mizusawa
Mar 20, 2014·Neurodegenerative Disease Management·Susana Pinto, Mamede de Carvalho
May 6, 2014·Clinical Neurology and Neurosurgery·Yasushi IwasakiMari Yoshida
Sep 8, 2015·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Georgia ChristodoulouJudith Rabkin
Jul 6, 2015·Journal of the Neurological Sciences·Yasushi IwasakiMari Yoshida
Oct 31, 2008·Journal of the Neurological Sciences·Naoki AtsutaUNKNOWN Research Committee on the Neurodegenerative Diseases of Japan
Apr 21, 2007·Journal of the Neurological Sciences·Janet E McLeod, David M Clarke
Jul 13, 2005·Journal of the Neurological Sciences·Nicole BurchardiJochen Vollmann
May 4, 2011·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Jane E HugginsKirsten L Gruis
Mar 10, 2012·The Gerontologist·Mindy Chettih
Mar 9, 2011·Palliative Medicine·Harriet PrestonDouglas J Mitchell
Apr 15, 2006·Palliative Medicine·Derek Eng
Jan 22, 2010·Nursing Ethics·Yuko Hirano, Yoshihiko Yamazaki
May 8, 2020·Prion·Jing YangHuifang Shang
May 8, 2018·Journal of Neurology·Peter M AndersenDorothée Lulé
Jun 7, 2006·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Judith G RabkinHiroshi Mitsumoto
Apr 12, 2014·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Judith RabkinHiroshi Mitsumoto
Jul 1, 2021·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Peter M AndersenDorothée Lulé